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Northern Ireland Surgical Trainees:
Prize Day November 2003
Abstacts from the Northern Ireland Surgical Trainees Prize Day, which was held on Friday 14
November2003andhostedbyAltnagelvinAreaHospitalatthe CityHotel,Londonderry. Thirty-
nine abstracts were submitted ofwhich eleven were accepted for presentation on the day. There
weresixintheSHOsectionandfiveintheSpecialistRegistrarsection. Winnerofthe SHOsection
was Dr Peter Mallon and runner-up was Conor Marron. Winner of the SpR section was Mr
Damian Mole and runner-up was Ms Janne Bingham.
THE IMPACT OF A COMPLIANT ROTA ON SHO
TRAINING EXPERIENCE AND SERVICE
COMMITMENT
C D Marron, C K Byrnes, S J Kirk
Department of Surgery, Ulster Hospital Dundonald
Introduction
Reductionofjuniordoctorshourshasbeendriven
by health care modernisation, and legislation.
Effective reduction has been achieved by the
introduction ofshift working. This change is not
universally accepted, many feel it is detrimental




The activities of a cohort of six senior house
officers (SHO's) in a general surgical unit were
assessed. Information was collected over two
consecutive six week periods before and after
switching from an "on-call" to a full shift rota.
Workingpattern information was obtainedfrom,










A total of 792 operations, 710 endoscopies, and
2649 outpatient episodes were analysed. Total
hours worked was reduced by the shift system,
however, alargerproportion ofthehours worked
was during the out-of-hours period. Total
outpatient and operative throughput did not
change.
With the shift system the total number or
proportion of operative cases attended did not
significantly change. There was a 37% reduction
in SHO attendance at inpatient elective cases.
Attendance at emergency operations and day
case surgery increased by 17% and 42%
respectively. There was a marked reduction in
exposure to endoscopy and outpatient
management (Table).
Conclusion
Change to a shift system leads to reduction in
clinical exposure in some key areas. However,
increased exposure is noted in emergency and
day case experience. If the shift system is not
adequately structured valuable learning
opportunities may be wasted. Optimising
timetable and shiftplanning may allow adequate
and appropriate training opportunities in the
available time.
PROMOTING EFFECT OF GASTRO-DUODENAL
REFLUX ON OESOPHAGEAL TUMORIGENESIS
A A C Menezesa, P Bondeb, Z Bella, S Mirvishc,
CSwarbrickd, JSloanW, SMcKeowne, TRobsone,
D Hirste, M Hopera, K Khosraviania, F C
Campbella, J A McGuiganb
aDepartment ofSurgery,
bDepartment ofCardio-thoracic
Surgery, dDepartment of Pathology, Queen's University
of Belfast, c Eppley Institute for Research in Cancer,
UniversityofNebraskaMedicalCenter,Omaha,NE,USA,
eSchool of Biomedical Sciences, University of Ulster.
C The Ulster Medical Society, 2004.The UlsterMedical Journal
Background
There appears to be a link between gastro-
oesophageal reflux disease and rising incidence
of oesophageal cancer in the West. We
hypothesised that increasing severity of reflux
enhancesproliferationandtumourformationwith
orwithoutexposuretodietarycarcinogen(methyl-
n-amylnitrosamine, MNAN). Toachievethis we
created a first model of mild to moderate reflux
by surgically destroying the cardiac and pyloric
sphincter (Model I). The severe reflux model
consistedofsidetosideanastomosisofduodenum
with lower oesophagus without gastric bypass
(Model II).
Methods
Sprague Dawley (8 week old, male) rats were
randomly assigned to 6 groups (as per Table).
MNAN (25mg/kg/wk) was injected
intraperitoneally at the age of 10 weeks or two
weeks following surgery to Group E for one
week, and remaining groups for four weeks. The
experiment was terminated when the animals
reached38 weeksofage. Thestudywasapproved
by animal ethics committee.
Results
Hyperproliferative ulcerative lesions (including
tumours) increased with severity of the reflux,
from 15% in Model I to 81% in Model II with
mutagen treatment, (p<O.Ol). Highest tumour
yield was in Group F (p<0.05). None of the
animals inthestudysufferedweightloss. Twelve
animals failed to complete the study.
TABLE
Group Group Group Group Group Group
A B C D E F
Control MNAN Model I Model II Modell+ Model II
(n=7) (n=15) (n=15) (n=15) MNAN +MNAN
(n=15) (n=15)
Animals
completed study 7 15 13 11 13 11
Tumours 0 3(20%) 0 1(9%) 0 5(45%)
Polypoid lesions 0 8(54%) 0 0 0 2(18%)
Hyperproliferative
ulcerative lesions 0 0 2(15%) 8(72%) 3(23%) 9(81%)
Normal oesophagus 7 7(47%) 11(85%) 3(27%) 10(77%) 2(18%)
Weight gain in 30
weeks(gms) 299±57 260.7±58.5 245.8±19 291.5±54.7 201.8±25 223±52.8
Conclusions
Gastro-duodenal reflux promotes epithelial
proliferation, tumour formation and enhances
cancerriskofadietarymutagen. This stresses the
role of anti-reflux treatment.
DOES IRRITABLE BOWEL SYNDROME
INFLUENCE THE INCIDENCE OF POST
CHOLECYSTECTOMY SYMPTOMS IN THE
LAPAROSCOPIC ERA?
P Mallon, J White, N Das, M McMenamin, D
Hughes, P Neilly, R Gilliland
Altnagelvin Hospital, Londonderry, Northern Ireland
Aim
An increase in the number ofcholecystectomies
performedhasbeennotedduringthelaparoscopic
era. Some authors have suggested that this may
be due to diagnostic confusion caused by
symptoms related to irritable bowel syndrome
(IBS). This study aimed to determine whether




Questionnaires were sent to two patient cohorts
who had undergone cholecystectomy between
1988-1990(open)and 1998-2000(laparoscopic).
Patients were asked about pain, jaundice and
indigestion pre- and postoperatively. Question-
naires also incorporated Rome II criteria for the
diagnosis of IBS and SF-36 quality of life data.
The histological severity of gallbladder disease
in both groups was assessed by a single
pathologist.
Results
124 of 196 patients in the open group and 264 of
400 patients in the laparoscopic group replied.
There was no difference between the groups in
gender, ageatsurgery,incidenceofpre-operative
symptoms, or the presence of positive Rome II
criteria. A higherpercentage ofpatients who had
opencholecystectomyhadreliefofpaincompared
to the laparoscopic group (81% vs. 70.6%:
p<O.05)*.Therewasnodifferenceintheincidence
ofIBS in patients who had persistent pain (open
50.0%; laparoscopic 50.0%; p=1.0) or any
symptoms post-cholecystectomy (open 40.0%:
laparoscopic 43.5%; p=0.85). There was no
difference between the groups with regards any
ofthe 8 domains specifiedwithinthe SF-36 data.
The mean histological scores of gallbladder
disease were similar in both groups.
Conclusions
While there is a significant increase in the
incidence of post cholecystectomy pain in the
laparoscopic group this cannot be attributed to
IBS and does not appear to influence quality of
life.
* Fishers exact test
C The Ulster Medical Society, 2004.
68Northern Ireland Surgical Trainees Prize Day
DOUBLE CONTRAST BARIUM ENEMAS - HOW
FREQUENT ARE REPORTS INCONCLUSIVE
AND WHAT ACTION IS TAKEN?
A Wray, G C Beattie, *R E R Wright, W J
Campbell
Department of *Radiology and Surgery, Ulster Hospital
Dundonald, Belfast, Northern Ireland.
Introduction
Double contrast barium enema (DCBE) in
combination withflexible sigmoidoscopy (FS) is
considered an adequate means ofvisualizing the
colorectum. In addition to the financial
implications of an inconclusive investigation,
clinicians are faced with the problem ofongoing
management. With a perceived increase in the
number of inconclusive DCBE reports and
requests for follow-up endoscopic visualization,
the aim of this study was to evaluate actual
numbers of each.
Methods
Reports of all DCBEs performed in the Ulster
Hospital inthecalendaryear2001 were obtained
from radiology computerized records. Reports
were divided into 3 main groups: i. Diagnostic
(normal enema or definite mucosal lesion); ii.
Complete technical failure; iii. Inconclusive
report. Thelatterreports werefurthersubdivided
into 4 groups according to the reason for
inadequate views: a. Poor bowel preparation; b.
Moderate/severe diverticular disease (DD); c.
Possiblepolypadvisingendoscopicvisualization;
d. Miscellaneous group - 'other' reasons. Charts
of all patients in 'inconclusive' group were
retrieved and reviewed.
Results
Of2036 DCBEs performed in 2001, radiologists
wereconfidentwiththeenema(definitepathology
or normal) in 1749 (86%). There were 77 (4%)
technical failures and 210 (10%) 'inconclusive'
DCBE's. Of the 210 inconclusive enemas, the
reason stated was poor bowel preparation in 58
(23%), DD in 70 (33%), possible mucosal polyp
recommending 'directvisualisation' in54(26%)
and 28 (13%) for 'other' reasons. Charts were
unavailable in 3 (1.4%) patients and 11 (5.2%)
patients didnotattendforfollow-up. In30(14%)
patients FS had already been carried out pre-
DCBE, with 1 abnormality detected. In96(46%)
patientsthereferringclinicianconsideredfurther
investigations inappropriate. In 70 (33.3%)
patients further investigations (rigid/FS or
colonoscopy) were arranged, 35 of whom were
fromthe 'directvisualisationrecommended' sub-
group. Of 70 endoscopies, 19 (27%) had an
abnormality which correlated to that queried on
DCBE, and 10 ofthese 19 were from the 'direct
visualisation' sub-group.
Conclusion
A significant number of DCBE reports are
inconclusive. The yield of significant mucosal
pathologywithfurtherendoscopicinvestigations
is low. Outpatient review and clinical risk
reassessment is recommended before arranging
furtherinvestigationsinpatientswithinconclusive
DCBE reports.
THE PREVALENCE OF SEXUAL DYSFUNCTION
IN MALE PATIENTS FOLLOWING ABDOMINAL
AORTIC ANEURYSM REPAIR IN NORTHERN
IRELAND
V Koo, A McKinley, P H Blair, J M Hood, L L
Lau.
Regional VascularUnit, Royal VictoriaHospital, Belfast.
Objective
Toinvestigatethefrequencyofsexualdysfunction
in male patients following abdominal aortic
aneurysm (AAA) repair in Northern Ireland.
Methods
After an initial screening by telephone contact, a
questionnaire-based survey using the validated
Sexual Health Inventory for Men (SHIM) was
carried out on 142 male patients who underwent
openorendovascularAAA(electiveandruptured)
repairbetween April 1999 toJuly 2002. A SHIM
score <21 predicts erectile dysfunction.
Demographics, medical history including pre-
existing sexual dysfunction, prostate surgery,
smoking status and sexual history, operative




21 endovascular (EVR) and 9 ruptured open
(RO) repair]. The mean age was 69 (EO), 73
(EVR) and 70 (RO) years old. The prevalence of
sexualdysfunctionpreoperativelywas27%(EO),
63% (EVR) and 45% (RO). About 35% (EO),
33%(EVR)and33Y% (RO)admittedtobesexually
inactive. Postoperative sexual dysfunction was
58% (EO), 76% (EVR) and 67% (RO). The
proportionofpatients withpostoperative erectile
dysfunction (SHIM score <21) was 70% (EO),
95% (EVR) and 78% (RO). The QoL was
worsened in 55% (EO), 75% (EVR) and 50%
C The Ulster Medical Society, 2004.
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(RO) postoperatively. None of patients had any
discussion about sexual dysfunction
preoperatively. Only 8% (EO), 14% (EVR) and
22% (RO) of patients had sexual dysfunction
discussed with their clinician post-surgery.
Conclusion
The prevalence ofpre- andpost-operative sexual
dysfunction is high in male patients who
underwent AAA repair. While it is a sensitive
issue which is seldom discussed, it poses a
significant impact on patient's QoL
postoperatively. Elective open repairresults in a
significantlyhigherincreaseofsexualdysfunction
compared to endovascular procedure.
SURVIVAL FROM BREAST CANCER IN
NORTHER IRELAND - WHAT REALLY
MATTERS?
lain Dobie', Karen Bailie2, Michael Donnelly3,
Stephen Kirk'
I Ulster Hospital, Dundonald, Belfast, 2Clinical Research
Support Centre, Belfast. I Dept Epidemiology & Public
Health, QUB, Belfast.
Background
Cancer survival outcomes for patients in the UK
arepoorerthaninEuropeandUS.CancerServices
reorganisation aims to address this through
concentratingcareinhighvolumesettingsbecause
apositive relationship between high volume and
bettersurvivalhasbeenreported. However,these
studies have inadequate adjustment for casemix,
a major determinant of outcome. We examined
this issue among patients with breast cancer in
Northern Ireland.
Methods
Records of all patients with invasive primary
breastcancerinNorthernIrelanddiagnosedduring
1996 (N=809) were reviewed in 1997 and again
in 2002. Patient, disease and service variables
and treatment decisions and date of death as of
31/12/2001 were extracted. Deaths were
corroborated using death registrations. Cox
Proportional Hazards models were used to
examine the relationship of patient, disease and
service variables to the risk of death.
Results
Among 807 (99%) patients traced for follow up,
therewere262deaths. Theoverall 5 yearsurvival
was68%o. Advancing age, late stagedisease, poor
Nottingham prognostic index, and higher social
deprivation (Townsend score), were
independently associated with lower survival
(p<0.05). A survival advantage forradiotherapy
treated patients was evident (OR 0.65, 95%CI
0.47-0.90)., and hormonal therapy (OR 0.49,
95%CI 0.30- 0.83). Using 230 cases pa to
distinguish high/low volume, survival was lower
for patients treated in low volume settings (OR
1.40, 95%CI 1.08-1.82) after adjustment for
casemix.
Conclusions
Patient and disease variables, radiotherapy and
hormonal therapy are the major determinants of
outcome forpatients withbreastcancer. There is
limited evidence to support a small advantage to
treatment in a high volume setting. Residual
confounding by casemix is a strong possibility.
THE ADMINISTRATION OF ENTERAL FATTY
ACID REDUCES THE GUT DYSFUNCTION
CAUSED BY METHOTREXATE
ADMINISTRATION
J Bingham, *M Scott, S J Kirk, K R Gardiner
Departments of Surgery and Pathology*, Institute of
Clinical Science, Grosvenor Road, Belfast, BT12 6BJ,
Northern Ireland.
Background
A side effect of methotrexate (MTX)
administration is gastrointestinal inflammation.
This study investigated the effect of enterally
administered fish oils on gut mucosal structure
and barrier function in an experimental animal
model of MTX induced mucositis.
Methods
Sprague-Dawley rats were randomized into 4
groups (n=20 per group). One group received
2.5mls/kgofMaxEPAfishoil,onegroupreceived
5.Omls/kgofMaxEPAfishoil,onegroupreceived
isocaloric safflower oil and one group received
20mls/kgwater.Eachtreatmentwasadministered
twice dailyby orogastric gavage fortendays. On
day seven each animal received 5.0mg/kg MTX
by subcutaneous injection for three consecutive
days.Foodintakeandbodyweightwererecorded
daily. On day eleven intestinal permeability was
assessed by measuring urinary excretion of
intragastric 14C-labelled polyethylene glycol
4000. At laparotomy on day twelve, blood was
sampled for measurement of plasma EndoCAb
and IL-6 concentrations and small bowel excised
for assessment of inflammation. Statistical
analysis wasperformedusingtheMann-Whitney
U test with significance taken as p<0.05.
C The Ulster Medical Society, 2004.
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Results
When compared to the group receiving water,
MaxEPA administration increased food intake
(p=O.OOO) and reduced plasma EndoCAb
(p=O.OOO) and IL-6 (p=0.017) concentrations.
Doubling the dose of MaxEPA caused weight
gain (p=O.OOO) and improved intestinal
permeability (p=0.041) in addition to increased
food intake (p=O.OOO), EndoCAb (p=O.OOO) and
IL-6 (p=0.030) concentrations. It also reduced
small bowel inflammation (p<0.05). When
compared to the group receiving isocaloric
saffloweroil, neitherdose ofMaxEPA improved
food intake, weight gain, small bowel
inflammation, intestinal permeability or plasma
EndoCAb or IL-6 concentration (p>0.05).
Conclusions
MTX induces small bowel mucositis.
Administrationof5.Omls/kgenteralomega-3fatty
acidreduces the gut mucosal barrierdysfunction
caused by MTX when compared with water but
not with an isocaloric control. The observed
improvement in gut mucosal barrier function
maysimplyreflectasupplementalcalorificeffect.
INTESTINAL INTRAMUCOSAL pH AS AN
INDICATOR OF LONG TERM PROGNOSIS IN
PATIENTS UNDERGOING AORTIC SURGERY
J A Reid, G Annamalai, L L Lau, C V Soong
Regional Vascular and Endovascular Unit, Belfast City
Hospital, UK
Introduction
The development of intestinal intramucosal
acidosishasbeenshowntobepredictiveofbowel
ischaemia. It is thought that the release of
myocardial depressantfactorfromthe ischaemic
bowel may be responsible for cardiac
complications following abdominal aortic
aneurysm repair. However, it is possible that
cardiac insufficiency during aortic surgery may
result in intestinal ischaemia. The aim of this
study is therefore to assess ifsigmoid ischaemia
is aprognostic indicatorofcardiacmorbidity and
mortality.
Materials and methods
Thirty-eight patients undergoing elective AAA
repair were recruited. Demographic details and
risk factors for heart disease were recorded.
Sigmoid pHi, as an indicator of ischaemia, was
measuredusingasiliconetonometerinallpatients
during and for 24h after operation. Seven years
following surgery the patients and their general
practitioners were contacted to determine the
patient's health.
Results
Within the follow-up period, 22 patients had
died, 3 post-operatively. Eight patients died of
cardiac failure or myocardial infarction. There
was no significant difference in the demographic
and risk factor details between the cardiac and
non-cardiac deaths. However there was a strong
positive correlation between those with
preoperative angina and those who developed
cardiac complications postoperatively (r=0.76).
There was no difference in aortic clamp time and
operation time between the two groups. No
correlation was observed between clamp time
and pHi. The pHi in patients with cardiac related
deaths (6.9±0.007) was significantly lower than
thosewithnon-cardiacrelateddeaths (7.1±0.006,
p<O.05). Similarly,patientswhosufferedcardiac
events following AAA repair had lower pHi
(6.9±0.05) compared to those who did not
(7.1±0.05, p<O.05).
Conclusion
The results suggest that global hypoperfusion as
a result of an under performing heart may be
partly responsible for the sigmoid ischaemia in
patients following AAA repair. Therefore, low
sigmoidpHimaybe ausefulprognostic indicator
ofcardiaccomplications inthisgroupofpatients.
TNF ALPHA, IL-1BETA AND IL-6 PRODUCTION
BY THE ISOLATED PERFUSED LIVER IN
RESPONSE TO A "SECOND HIT" OF PORTAL
ENDOTOXIN IS NOT ENHANCED BY
EXPERIMENTAL SEVERE ACUTE
PANCREATITIS
D J Mole', M A Taylor1, J Black', M Hoperl, A
Stockman2, N V McFerran3 and T Diamond'.
Surgery' and Pathology2, School of Medicine, Queen's
University Belfast, and School of Biology and
Biochemistry3, Queen's University Belfast.
Background
Severe acute pancreatitis (AP) may enhance
hepatic cytokine production in response to a
"second hit", such as portal endotoxaemia
resulting from gut-barrier dysfunction.
Aim
Toevaluatelivercytokineproductioninresponse
to a "second hit" of portal endotoxin during
severe AP.
C) The Ulster Medical Society, 2004.
71The Ulster Medical Journal
Methods
Twenty-fourrats wererandomizedinto 3 groups:
AP (n=10), sham-operated (n=8), and non-
operated controls (n=6). Severe AP was induced
at laparotomy by intraductal glycodeoxycholate
injectionandintravenouscaeruleininfusion. 18hr
afterinduction ofAP a"second hit" ofendotoxin
(10tg/kg over 10min) was delivered into the
portal vein in an isolated liver perfusion system.
TNF-alpha, IL-Ibeta and IL-6 were measured in
effluent perfusate collected at 30-40min and 90-
100min into perfusion. Liver viability was
assessed by oxygen consumption, biochemistry,
histology and electron microscopy. Kupffer cell
populations were quantified by immuno-
histochemistry.
Results
A systemic inflammatory response to AP was
demonstratedbyelevatedhaematocrit,metabolic
acidosis and 20% mortality.
At 18hr a pronounced transhepatic serum IL-6
gradientwas observedinAP: 96pg/ml (portal) vs
621pg/ml (IVC) (P<0.001, Wilcoxon). Sham/
control IL-6 was undetectable. IL-lbeta was
elevated in AP and sham serum. In AP, a small
transhepatic serum IL-lbeta gradient was
detected: 64pg/ml (portal) vs 74pg/ml (IVC)
(P<0.025, Wilcoxon). Serum TNF-alpha was
<6pg/ml in all groups.
"Second hit": Portal endotoxaemia stimulated
hepatic TNF-alpha production by 90-lOOmins:
AP: 61pg/ml; sham: 1 2pg/ml; control: 61pg/ml;
P=0.864 between groups; 90-lOOmins vs. 30-
40mins,P<0.001 foreachgroup(Kruskal-Wallis).
No IL-6 or IL-Ibeta was detected at 90-1O0mins
in any group.
Observation of normal smooth endoplasmic
reticulum, mitochondria, oxygen consumption
and minor vacuolation indicated minimal liver
disruption.
Normal ED1-positive Kupffer cell distributions
were seen in perfused livers.
Conclusion
Transhepatic pro-inflammatory cytokine
gradients occur during experimental severe AP
in rats. The isolated perfused liver TNF-alpha,
IL-libeta and IL-6 production response to portal
endotoxinisnotdifferentiallyenhancedinsevere
AP.
ATTENUATION OF THE "SECOND HIT"-
INDUCED HEPATIC CYTOKINE RESPONSE IN
OBSTRUCTIVE JAUNDICE USING NOVEL ANTI-
ENDOTOXIN PEPTIDES
MATaylor 1,JMBlack 1,AWallace 2,MHoper
WDB Clements 1,NVMcFerran 2,MCRegan
T Diamond 1
'DepartmentofSurgeryand2CentreforPeptideandProtein
Engineering, TheQueen's University ofBelfast, Northern
Ireland, I University College Hospital, Galway.
Background
Therapeutic intervention in patients with
obstructive jaundice (OJ) may be regarded as a
second hit, capable of increasing endotoxaemia
with subsequent exaggerated hepatic
proinflammatory cytokine production. The aim
of this study was to assess the efficacy of novel
anti-endotoxinpeptides(P6andC1)inattenuating
the hepatic TNF± and IL-6 response to a second





minnesota Re995. A nine-amino acid peptide,
P6, was developed which was shown to inhibit
LPS-induced TNF± secretion by human
monocytic cells and a second peptide, C1, was
generated by substituting amino acids of
complimentary charge to the original. Bile duct
ligation was performed on 15 Male Wistar rats
which were randomised to receive either (A)
endotoxin(LPS) alone (n=5), (B)LPS +P6 (n=5)
or (C) LPS + Cl (n=5) during in-situ hepatic
perfusion performed over 2 hours, 1 week post
surgery. Effluent perfusate was collected for
cytokine analysis (TNF± and IL-6) at 20 min
intervals.
Results
Repeated measures analysis over time of the
effluent TNF± and IL-6 concentrations between
the three groups (A, B and C) was carried out.
TNF±: There was a significant difference in
effluentlevelsbetweenthethreegroups(p=0.04)
with post hoc analysis (Duncan's test)
demonstrating significantlylowerconcentrations
ofTNF± in groups B and C compared to A. IL-6:
There was no significant difference in effluent
levels between the three groups (p=0.16) using
repeated measures analysis but at 2 hours there
appeared to be higher levels of IL-6 in group A.
© The Ulster Medical Society, 2004.
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Conclusion
These novel anti-endotoxin peptides, capable of
attenuatingtheLPS-inducedexaggeratedhepatic
cytokine response, may offer an exciting new
therapeutic strategy for reducing intervention -
related complications in OJ.
OPTIMISING BOWEL PREPARATION FOR OUT-
PATIENT FLEXIBLE SIGMOIDOSCOPY: A
PROSPECTIVE RANDOMISED SINGLE BLIND
COMPARISON OF THREE METHODS




for colorectal symptoms. One phosphate enema
has been the standard bowel preparation for out-
patient sigmoidoscopy but provides adequate
preparation in only 80% of patients. This study
aimed to compare two methods of bowel
preparationwiththecurrentstandardinanattempt
to improve efficacy and acceptability.
Methods
Patients attending for out-patient flexible
sigmoidoscopy from January to September 2003
were randomised to 3 groups:- Group 1: One
Fleet enema two hours pre-procedure; Group 2:
Two Fleet enemas, one during evening prior to
sigmoidoscopy andonetwohourspre-procedure;
Group 3: Lactulose 30mls orally 48 and 24 hours
priorto sigmoidoscopy plus asingle Fleet enema
two hours pre-procedure. A questionnaire was




261 patients (Group 1:n=105; Group 2:n=81;
Group 3:n=75) were included; endoscopist data
was available for 251 (Group 1:n=97; Group
2:n=79; Group 3:n=75). Nodifference was noted
between the groups with regards age, gender,














Group 1 94% 19% 48% 18% 83%
Group 2 85% 11% 46% 28% 88%
Group 3 87% 24% 36% 23% 73%
P value 0.09' 0.151 0.35' 0.25' 0.04'
There was no difference in the quality of
preparation of patients in Group 1 vs. Group 2
(p=0.392) or Group 1 vs. Group 3 (p=O.132).
However, two Fleet enemas gave superior
preparation compared with the lactulose + Fleet
group (p=0.022).
Conclusions
The addition of a Fleet enema or oral lactulose
over and above a single fleet enema gives no
significant improvement in acceptability or
efficacy.
' Chi-squared; 2 Fishers exact test
© The Ulster Medical Society, 2004.
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